Therapeutic Advances in Vaccines and Immunotherapy最新文献

筛选
英文 中文
Routine immunization for children in the Philippines: challenges and interventions. 菲律宾儿童常规免疫接种:挑战与干预措施。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2024-06-24 eCollection Date: 2024-01-01 DOI: 10.1177/25151355241264528
Dalmacito A Cordero
{"title":"Routine immunization for children in the Philippines: challenges and interventions.","authors":"Dalmacito A Cordero","doi":"10.1177/25151355241264528","DOIUrl":"https://doi.org/10.1177/25151355241264528","url":null,"abstract":"","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"12 ","pages":"25151355241264528"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring social media influences on vaccine decision-making in parents: a netnography. 探究社交媒体对家长疫苗决策的影响:一项网络研究。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2024-05-08 eCollection Date: 2024-01-01 DOI: 10.1177/25151355241249607
Susan E Smith, Nina Sivertsen, Lauren Lines, Anita De Bellis
{"title":"Exploring social media influences on vaccine decision-making in parents: a netnography.","authors":"Susan E Smith, Nina Sivertsen, Lauren Lines, Anita De Bellis","doi":"10.1177/25151355241249607","DOIUrl":"10.1177/25151355241249607","url":null,"abstract":"<p><strong>Background: </strong>Immunization is one of the most significant health initiatives of recent times. Despite this, vaccine hesitancy is increasing and was listed as one of the top 10 threats to global health by the World Health Organization in 2019. A major factor associated with vaccine hesitancy is thought to be the viral spread of misinformation by a small but active anti-vaccination movement.</p><p><strong>Objectives: </strong>The purpose of this study was to explore the influences of social media on vaccine decision-making in parents.</p><p><strong>Design: </strong>This study is part of a larger body of research that explored vaccine decision-making in parents. Other methods included were an online survey and semi-structured interviews. This study investigated the influence of cyberculture on parents in an online environment.</p><p><strong>Method: </strong>This study employed netnography, a form of qualitative inquiry with its roots in ethnography as methodology and a purpose-designed Facebook page as the means of exploring a purpose-designed online community with a particular focus on the culture, belief systems and influences present. Both manual and computer-assisted thematic analyses were used to analyse the data obtained.</p><p><strong>Results: </strong>Three key themes were identified in this study. These included vaccine safety concerns, the emotional debate and COVID-19-specific issues. The results indicated the presence of strong anti-vaccination sentiment combined with an 'infodemic' of conspiracy theories, misinformation and vitriol with the potential to negatively impact parents seeking immunization information.</p><p><strong>Conclusion: </strong>Given the popularity and accessibility of social media and the ready access to misinformation present online, it is evident that parental vaccine decision-making may be impacted adversely. Therefore, it is important that healthcare professionals are aware of this and provide adequate and timely education prior to parents seeking information on social media.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"12 ","pages":"25151355241249607"},"PeriodicalIF":0.0,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11080448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome. COVID-19 疫苗中的佐剂:挑起 COVID 心脏综合症的无辜旁观者还是罪魁祸首?
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2024-02-04 eCollection Date: 2024-01-01 DOI: 10.1177/25151355241228439
Sri Harsha Kanuri, Prapthi Jayesh Sirrkay
{"title":"Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome.","authors":"Sri Harsha Kanuri, Prapthi Jayesh Sirrkay","doi":"10.1177/25151355241228439","DOIUrl":"10.1177/25151355241228439","url":null,"abstract":"<p><p>COVID-19 infection is a multi-system clinical disorder that was associated with increased morbidity and mortality. Even though antiviral therapies such as Remdesvir offered modest efficacy in reducing the mortality and morbidity, they were not efficacious in reducing the risk of future infections. So, FDA approved COVID-19 vaccines which are widely administered in the general population worldwide. These COVID-19 vaccines offered a safety net against future infections and re-infections. Most of these vaccines contain inactivated virus or spike protein mRNA that are primarily responsible for inducing innate and adaptive immunity. These vaccines were also formulated to contain supplementary adjuvants that are beneficial in boosting the immune response. During the pandemic, clinicians all over the world witnessed an uprise in the incidence and prevalence of cardiovascular diseases (COVID-Heart Syndrome) in patients with and without cardiovascular risk factors. Clinical researchers were not certain about the underlying reason for the upsurge of cardiovascular disorders with some blaming them on COVID-19 infections while others blaming them on COVID-19 vaccines. Based on the literature review, we hypothesize that adjuvants included in the COVID-19 vaccines are the real culprits for causation of cardiovascular disorders. Operation of various pathological signaling events under the influence of these adjuvants including autoimmunity, bystander effect, direct toxicity, anti-phospholipid syndrome (APS), anaphylaxis, hypersensitivity, genetic susceptibility, epitope spreading, and anti-idiotypic antibodies were partially responsible for stirring up the onset of cardiovascular disorders. With these mechanisms in place, a minor contribution from COVID-19 virus itself cannot be ruled out. With that being said, we strongly advocate for careful selection of vaccine adjuvants included in COVID-19 vaccines so that future adverse cardiac disorders can be averted.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"12 ","pages":"25151355241228439"},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10846003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons learned from a cluster of immunization errors in newborns. 从一组新生儿免疫接种错误中汲取教训。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2024-01-02 eCollection Date: 2024-01-01 DOI: 10.1177/25151355231221009
Loubna Alj, Amina Tebaa, Ismail Talibi, Sofia Moubarik, Mohammed Benazzouz, Rachida Soulaymani Bencheikh
{"title":"Lessons learned from a cluster of immunization errors in newborns.","authors":"Loubna Alj, Amina Tebaa, Ismail Talibi, Sofia Moubarik, Mohammed Benazzouz, Rachida Soulaymani Bencheikh","doi":"10.1177/25151355231221009","DOIUrl":"10.1177/25151355231221009","url":null,"abstract":"<p><strong>Background: </strong>Vaccines are safe and effective, but adverse reactions can occur. Immunization errors (IEs) are one of the types of adverse events following immunization. The Moroccan Pharmacovigilance Centre (MPC) received a cluster of IEs from a maternity university hospital (MUH) regarding six newborns who were inadvertently administered rocuronium instead of hepatitis B (HepB) vaccine. The newborns experienced respiratory distress and one had a fatal outcome.</p><p><strong>Objectives: </strong>The study aimed to describe the investigation findings, the underlying causes, and contributing factors of the IEs cluster, and proposed risk minimization actions.</p><p><strong>Design: </strong>We carried out a descriptive analysis of the cluster of IEs related to the HepB vaccine reported to the MPC.</p><p><strong>Methods: </strong>An investigation was conducted by the Ministry of Health according to the World Health Organization guidance. The root cause analysis was performed to identify underlying causes and contributing factors that lead to IE occurrence.</p><p><strong>Results: </strong>The cluster analysis showed that the main contributing factors were the look-alike rocuronium and HepB vaccine packaging, the first-time running HepB vaccination for newborns in the MUH, the lack of a full-time pharmacist, and the unsafe storage of rocuronium and vaccines. The administration of Sugammadex to the newborns followed by their transfer to the neonatal care unit resulted in the recovery of five of the six newborns. Proposed recommendations included (1) raising awareness of healthcare professionals to the risk related to look-alike medications, (2) training nurses to ensure vaccination to implement procedures related to immunization practices, (3) nomination of a full-time pharmacist, (4) reassessment of the safety of drug storage and dispensing at the hospital pharmacy, particularly for high-alert medications.</p><p><strong>Conclusion: </strong>Reporting IEs, particularly serious ones, allows us to identify causes and contributing factors that led to their occurrence. Lessons learned from errors are key to take risk minimization actions to improve vaccine safety worldwide.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"12 ","pages":"25151355231221009"},"PeriodicalIF":0.0,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139098829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing disparities in funding for robust cancer research. 解决癌症研究资金不足的问题。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2023-12-15 eCollection Date: 2023-01-01 DOI: 10.1177/25151355231219083
Dalmacito A Cordero
{"title":"Addressing disparities in funding for robust cancer research.","authors":"Dalmacito A Cordero","doi":"10.1177/25151355231219083","DOIUrl":"https://doi.org/10.1177/25151355231219083","url":null,"abstract":"","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"11 ","pages":"25151355231219083"},"PeriodicalIF":0.0,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138810615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan 停滞还是安全?重新评估日本的人类乳头瘤病毒疫苗接种剂量方案
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2023-12-11 DOI: 10.1177/25151355231216408
M. Namba, Yudai Kaneda, Miho Iida
{"title":"Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan","authors":"M. Namba, Yudai Kaneda, Miho Iida","doi":"10.1177/25151355231216408","DOIUrl":"https://doi.org/10.1177/25151355231216408","url":null,"abstract":"","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"2 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138584399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of oral mefenamic acid versus paracetamol as a prophylactic analgesic for needle pain in children receiving vaccination: a three-arm, parallel, triple-blind, placebo-controlled MAP VaC randomized controlled trial. 口服甲灭酸与扑热息痛作为预防性镇痛剂对接受疫苗接种儿童针刺疼痛的疗效:一项三臂、平行、三盲、安慰剂对照的 MAP VaC 随机对照试验。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2023-12-06 eCollection Date: 2023-01-01 DOI: 10.1177/25151355231216122
Rachna Pasi, Thirunavukkarasu Arun Babu, Vinoth Kumar Kallidoss
{"title":"Efficacy of oral mefenamic acid <i>versus</i> paracetamol as a prophylactic analgesic for needle pain in children receiving vaccination: a three-arm, parallel, triple-blind, placebo-controlled MAP VaC randomized controlled trial.","authors":"Rachna Pasi, Thirunavukkarasu Arun Babu, Vinoth Kumar Kallidoss","doi":"10.1177/25151355231216122","DOIUrl":"https://doi.org/10.1177/25151355231216122","url":null,"abstract":"<p><strong>Background: </strong>Needle pain due to routine vaccination is an important factor contributing to low vaccine adherence and immunization coverage. Prophylactic oral analgesics can address this important issue of needle pain related to vaccination. Paracetamol and mefenamic acid are commonly used nonsteroidal anti-inflammatory drugs for pain relief, but there is little published literature on whether the same can be used for needle pain related to vaccination.</p><p><strong>Objectives: </strong>This study was planned to compare the efficacy of oral mefenamic acid and paracetamol over placebo as a prophylactic analgesic during vaccination and prophylactic antipyretic during the post-vaccination period.</p><p><strong>Designs: </strong>Three-arm, triple-blind, randomized controlled trial.</p><p><strong>Methods: </strong>This study was conducted at the outpatient department of a tertiary-level medical college in South India from January 2021 to June 2022. In this three-arm interventional trial, each arm had either a single dose of placebo or mefenamic acid (4 mg/kg/dose) or paracetamol (10 mg/kg/dose). These medicines were administered orally 30 min before vaccination to reduce needle pain.</p><p><strong>Main outcome and measures: </strong>Outcome was measured with the change of FLACC (Face, Leg, Activity, Cry, Consolability) scoring at the time of vaccination, subsequently at 15 and 30 min of vaccination in all three groups. Appearance of fever, grade of fever, and need for antipyretics 24 h after vaccination were also noted.</p><p><strong>Results: </strong>There was a significant difference in FLACC scores at the time of administration (<i>p</i> = 0.010) and at 15 min (<i>p</i> = 0.014) with mefenamic acid compared to placebo. Although the paracetamol group showed a difference when compared to the placebo, it was not significant at the time of administration (<i>p</i> = 0.401), at 15 min (<i>p</i> = 0.451), or 30 min (<i>p</i> = 0.892) post-vaccination. The appearance of fever, grade of fever, and use of antipyretic up to 24 h post-vaccination had no significant difference among any of the three groups.</p><p><strong>Conclusion: </strong>Mefenamic acid was more potent than placebo for pre-vaccination pain prophylaxis in children. There was no difference in the appearance of fever and its grade among the three groups. The promising results from this trial warrant further large-scale studies to recommend a single oral dose of mefenamic acid to tackle needle pain related to vaccination in children to improve vaccine adherence and coverage.</p><p><strong>Trial registration: </strong>CTRI (Clinical trials registry-India) (CTRI/2021/01/030239). [Date of Commencement: 13 Jan 2021, Date of last recruitment: 30 June 2022 (now closed for new participants)].</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"11 ","pages":"25151355231216122"},"PeriodicalIF":0.0,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10702398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138810620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flu vaccination in the Philippines: challenges and interventions. 菲律宾的流感疫苗接种:挑战和干预措施。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2023-11-17 eCollection Date: 2023-01-01 DOI: 10.1177/25151355231213587
Dalmacito A Cordero
{"title":"Flu vaccination in the Philippines: challenges and interventions.","authors":"Dalmacito A Cordero","doi":"10.1177/25151355231213587","DOIUrl":"https://doi.org/10.1177/25151355231213587","url":null,"abstract":"","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"11 ","pages":"25151355231213587"},"PeriodicalIF":0.0,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138463069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Designing an inclusive immunization schedule for children and adults in India. 为印度儿童和成人设计包容性免疫计划。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2023-11-17 eCollection Date: 2023-01-01 DOI: 10.1177/25151355231213573
Farah Niazi, Karuna Nidhi Kaur, Shazina Saeed, Mohd Shannawaz
{"title":"Designing an inclusive immunization schedule for children and adults in India.","authors":"Farah Niazi, Karuna Nidhi Kaur, Shazina Saeed, Mohd Shannawaz","doi":"10.1177/25151355231213573","DOIUrl":"https://doi.org/10.1177/25151355231213573","url":null,"abstract":"","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"11 ","pages":"25151355231213573"},"PeriodicalIF":0.0,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138463068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccine immune response and plasma cell dyscrasia. COVID-19疫苗免疫反应与浆细胞病变。
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2023-11-09 eCollection Date: 2023-01-01 DOI: 10.1177/25151355231209733
Amnuay Kleebayoon, Viroj Wiwanitkit
{"title":"COVID-19 vaccine immune response and plasma cell dyscrasia.","authors":"Amnuay Kleebayoon, Viroj Wiwanitkit","doi":"10.1177/25151355231209733","DOIUrl":"10.1177/25151355231209733","url":null,"abstract":"","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"11 ","pages":"25151355231209733"},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89719747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书